Peripheral Artery Disease (PAD) Resources
For Patients and Health Care Professionals
Peripheral artery disease affects over 8.5 million U.S. adults and over 113 million people worldwide. The American Heart Association and the Anticoagulation Forum are joining forces to elevate awareness of PAD among patients and health care professionals. Join us in this effort!
The most common symptoms of lower-extremity PAD are cramping, pain or tiredness in the leg or hip muscles while walking, climbing stairs or exercising.
If you have diabetes, you have an especially high risk for PAD. People with PAD also have a higher risk of coronary artery disease, heart attack and stroke.
Tools for Health Care Professionals
View the three-part PAD Webinar Series created by the American Heart Association through an educational fund from Janssen. Pad experts discuss assessing, treating and managing peripheral artery disease in diverse communities. Topics include: the clinical assessment of PAD on the primary care spectrum with Dr. Eileen Walsh; treating PAD in underserved communities with Dr. Antonio Gutierrez and Dr. Amy West Pollack; and exercise therapy for PAD patients with Dr. Diane Treat-Jacobson.
Peripheral Artery Disease Roundtable ReportIn December 2018, the American Heart Association and National Heart, Lung, and Blood Institute jointly convened multidisciplinary health care professionals representing over 40 health organizations to a PAD Roundtable. They identified strategies to improve public awareness of PAD prevention and increase awareness of PAD recognition and management among patients and health care professionals. The outcome of the session is the PAD Roundtable Report.
Part of a series of etc talks created by the Anticoagulation Forum, Dr. Jeffrey Weitz gets to the heart of issues surrounding vascular health in under 10 minutes, with highlights from a recent study on combination therapy in vascular protection. Discover how treatment can benefit patients by reducing cardiovascular events while balancing risk of increased bleeding by exploring the COMPASS trial with Dr. Weitz.
In less than three minutes, Dr. Jeffrey Weitz will provide a simple graphic overview of how blood clots form and how to minimize risk factors associated with blood clots that can lead to heart attack, stroke and peripheral artery disease.
Data suggests that patients with symptomatic peripheral artery disease taking clopidogrel have a lower risk of cardiovascular events than those receiving aspirin. How does clopidogrel compare with ticagrelor in reducing major bleeding among these patients? Dr. Will Hiatt, lead author from the University of Colorado, explains this in depth during the 45-minute webinar.